IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2019-06, Vol.37 (S2), p.135-137 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 137 |
|---|---|
| container_issue | S2 |
| container_start_page | 135 |
| container_title | Hematological oncology |
| container_volume | 37 |
| creator | Morschhauser, F. Flinn, I.W. Gasiorowski, R. Illés, Á. Feugier, P. Greil, R. Johnson, N.A. Larouche, J. Lugtenburg, P.J. Patti, C. Salles, G. Trněný, M. Vos, S. Mir, F. Kornacker, M. Punnoose, E.A. Samineni, D. Szafer‐Glusman, E. Petrich, A. Sinha, A. Spielewoy, N. Humphrey, K. Bazeos, A. Zelenetz, A.D. |
| description | |
| doi_str_mv | 10.1002/hon.95_2629 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2242708483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242708483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1879-e130834f865b04dc260dc55c3c71b4a7b67d29f0527f28aa4ddd4be731cd86333</originalsourceid><addsrcrecordid>eNp9kU1u2zAUhImiAeomXfUCD-jGRqGUpP6o7hiZjghQpiBRbrMiZP2gCZI4lRoU2eUIOUxOlJOUrtNtV-8B883MYhD6SPApwZh--bG7PU1CSyOavEEzgpPEIzhK3qIZpjHzMPXpO_R-mq4wdhpmM_Qs86LUG7EEXZtU56ICuYaCGynWpoJ5YaoFfJMmg7NU0ZfHp0JX0siNgKVcrepKgOLluYAzJ6VCKVAXeZHpnMN8qZxlAaYU3Lj8vyEbsRZGp4p_h7n7F1CouoJyb8508RVKUdXK9a5KnYPJBBQZdx0UUr7hSkmoTL28OEFHQ3M99R9e7zGqV8Kkmaf0uUy58lrC4sTriY-ZHwwsCrc46Foa4a4Nw9ZvY7INmngbxR1NBhzSeKCsaYKu64JtH_uk7Vjk-_4x-nTIvRt3P-_76Ze92t2Pt67SUhrQGLOA7anPB6odd9M09oO9Gy9vmvHBEmz3s1g3i32dxdH-gf59ed0__A-1mV7_c_0B5UqEyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242708483</pqid></control><display><type>article</type><title>IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY</title><source>Wiley Online Library - AutoHoldings Journals</source><creator>Morschhauser, F. ; Flinn, I.W. ; Gasiorowski, R. ; Illés, Á. ; Feugier, P. ; Greil, R. ; Johnson, N.A. ; Larouche, J. ; Lugtenburg, P.J. ; Patti, C. ; Salles, G. ; Trněný, M. ; Vos, S. ; Mir, F. ; Kornacker, M. ; Punnoose, E.A. ; Samineni, D. ; Szafer‐Glusman, E. ; Petrich, A. ; Sinha, A. ; Spielewoy, N. ; Humphrey, K. ; Bazeos, A. ; Zelenetz, A.D.</creator><creatorcontrib>Morschhauser, F. ; Flinn, I.W. ; Gasiorowski, R. ; Illés, Á. ; Feugier, P. ; Greil, R. ; Johnson, N.A. ; Larouche, J. ; Lugtenburg, P.J. ; Patti, C. ; Salles, G. ; Trněný, M. ; Vos, S. ; Mir, F. ; Kornacker, M. ; Punnoose, E.A. ; Samineni, D. ; Szafer‐Glusman, E. ; Petrich, A. ; Sinha, A. ; Spielewoy, N. ; Humphrey, K. ; Bazeos, A. ; Zelenetz, A.D.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.95_2629</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>B-cell lymphoma ; Lymphocytes B ; Lymphoma</subject><ispartof>Hematological oncology, 2019-06, Vol.37 (S2), p.135-137</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1879-e130834f865b04dc260dc55c3c71b4a7b67d29f0527f28aa4ddd4be731cd86333</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.95_2629$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.95_2629$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Morschhauser, F.</creatorcontrib><creatorcontrib>Flinn, I.W.</creatorcontrib><creatorcontrib>Gasiorowski, R.</creatorcontrib><creatorcontrib>Illés, Á.</creatorcontrib><creatorcontrib>Feugier, P.</creatorcontrib><creatorcontrib>Greil, R.</creatorcontrib><creatorcontrib>Johnson, N.A.</creatorcontrib><creatorcontrib>Larouche, J.</creatorcontrib><creatorcontrib>Lugtenburg, P.J.</creatorcontrib><creatorcontrib>Patti, C.</creatorcontrib><creatorcontrib>Salles, G.</creatorcontrib><creatorcontrib>Trněný, M.</creatorcontrib><creatorcontrib>Vos, S.</creatorcontrib><creatorcontrib>Mir, F.</creatorcontrib><creatorcontrib>Kornacker, M.</creatorcontrib><creatorcontrib>Punnoose, E.A.</creatorcontrib><creatorcontrib>Samineni, D.</creatorcontrib><creatorcontrib>Szafer‐Glusman, E.</creatorcontrib><creatorcontrib>Petrich, A.</creatorcontrib><creatorcontrib>Sinha, A.</creatorcontrib><creatorcontrib>Spielewoy, N.</creatorcontrib><creatorcontrib>Humphrey, K.</creatorcontrib><creatorcontrib>Bazeos, A.</creatorcontrib><creatorcontrib>Zelenetz, A.D.</creatorcontrib><title>IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY</title><title>Hematological oncology</title><subject>B-cell lymphoma</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kU1u2zAUhImiAeomXfUCD-jGRqGUpP6o7hiZjghQpiBRbrMiZP2gCZI4lRoU2eUIOUxOlJOUrtNtV-8B883MYhD6SPApwZh--bG7PU1CSyOavEEzgpPEIzhK3qIZpjHzMPXpO_R-mq4wdhpmM_Qs86LUG7EEXZtU56ICuYaCGynWpoJ5YaoFfJMmg7NU0ZfHp0JX0siNgKVcrepKgOLluYAzJ6VCKVAXeZHpnMN8qZxlAaYU3Lj8vyEbsRZGp4p_h7n7F1CouoJyb8508RVKUdXK9a5KnYPJBBQZdx0UUr7hSkmoTL28OEFHQ3M99R9e7zGqV8Kkmaf0uUy58lrC4sTriY-ZHwwsCrc46Foa4a4Nw9ZvY7INmngbxR1NBhzSeKCsaYKu64JtH_uk7Vjk-_4x-nTIvRt3P-_76Ze92t2Pt67SUhrQGLOA7anPB6odd9M09oO9Gy9vmvHBEmz3s1g3i32dxdH-gf59ed0__A-1mV7_c_0B5UqEyg</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Morschhauser, F.</creator><creator>Flinn, I.W.</creator><creator>Gasiorowski, R.</creator><creator>Illés, Á.</creator><creator>Feugier, P.</creator><creator>Greil, R.</creator><creator>Johnson, N.A.</creator><creator>Larouche, J.</creator><creator>Lugtenburg, P.J.</creator><creator>Patti, C.</creator><creator>Salles, G.</creator><creator>Trněný, M.</creator><creator>Vos, S.</creator><creator>Mir, F.</creator><creator>Kornacker, M.</creator><creator>Punnoose, E.A.</creator><creator>Samineni, D.</creator><creator>Szafer‐Glusman, E.</creator><creator>Petrich, A.</creator><creator>Sinha, A.</creator><creator>Spielewoy, N.</creator><creator>Humphrey, K.</creator><creator>Bazeos, A.</creator><creator>Zelenetz, A.D.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201906</creationdate><title>IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY</title><author>Morschhauser, F. ; Flinn, I.W. ; Gasiorowski, R. ; Illés, Á. ; Feugier, P. ; Greil, R. ; Johnson, N.A. ; Larouche, J. ; Lugtenburg, P.J. ; Patti, C. ; Salles, G. ; Trněný, M. ; Vos, S. ; Mir, F. ; Kornacker, M. ; Punnoose, E.A. ; Samineni, D. ; Szafer‐Glusman, E. ; Petrich, A. ; Sinha, A. ; Spielewoy, N. ; Humphrey, K. ; Bazeos, A. ; Zelenetz, A.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1879-e130834f865b04dc260dc55c3c71b4a7b67d29f0527f28aa4ddd4be731cd86333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>B-cell lymphoma</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morschhauser, F.</creatorcontrib><creatorcontrib>Flinn, I.W.</creatorcontrib><creatorcontrib>Gasiorowski, R.</creatorcontrib><creatorcontrib>Illés, Á.</creatorcontrib><creatorcontrib>Feugier, P.</creatorcontrib><creatorcontrib>Greil, R.</creatorcontrib><creatorcontrib>Johnson, N.A.</creatorcontrib><creatorcontrib>Larouche, J.</creatorcontrib><creatorcontrib>Lugtenburg, P.J.</creatorcontrib><creatorcontrib>Patti, C.</creatorcontrib><creatorcontrib>Salles, G.</creatorcontrib><creatorcontrib>Trněný, M.</creatorcontrib><creatorcontrib>Vos, S.</creatorcontrib><creatorcontrib>Mir, F.</creatorcontrib><creatorcontrib>Kornacker, M.</creatorcontrib><creatorcontrib>Punnoose, E.A.</creatorcontrib><creatorcontrib>Samineni, D.</creatorcontrib><creatorcontrib>Szafer‐Glusman, E.</creatorcontrib><creatorcontrib>Petrich, A.</creatorcontrib><creatorcontrib>Sinha, A.</creatorcontrib><creatorcontrib>Spielewoy, N.</creatorcontrib><creatorcontrib>Humphrey, K.</creatorcontrib><creatorcontrib>Bazeos, A.</creatorcontrib><creatorcontrib>Zelenetz, A.D.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morschhauser, F.</au><au>Flinn, I.W.</au><au>Gasiorowski, R.</au><au>Illés, Á.</au><au>Feugier, P.</au><au>Greil, R.</au><au>Johnson, N.A.</au><au>Larouche, J.</au><au>Lugtenburg, P.J.</au><au>Patti, C.</au><au>Salles, G.</au><au>Trněný, M.</au><au>Vos, S.</au><au>Mir, F.</au><au>Kornacker, M.</au><au>Punnoose, E.A.</au><au>Samineni, D.</au><au>Szafer‐Glusman, E.</au><au>Petrich, A.</au><au>Sinha, A.</au><au>Spielewoy, N.</au><au>Humphrey, K.</au><au>Bazeos, A.</au><au>Zelenetz, A.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY</atitle><jtitle>Hematological oncology</jtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>S2</issue><spage>135</spage><epage>137</epage><pages>135-137</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.95_2629</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2019-06, Vol.37 (S2), p.135-137 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_2242708483 |
| source | Wiley Online Library - AutoHoldings Journals |
| subjects | B-cell lymphoma Lymphocytes B Lymphoma |
| title | IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IMPROVED%20OUTCOMES%20IN%20PATIENTS%20(PTS)%20WITH%20BCL2%E2%80%90POSITIVE%20DIFFUSE%20LARGE%20B%E2%80%90CELL%20LYMPHOMA%20(DLBCL)%20TREATED%20WITH%20VENETOCLAX%20(VEN)%20PLUS%20R%E2%80%90CHOP:%20RESULTS%20FROM%20THE%20PHASE%202%20CAVALLI%20STUDY&rft.jtitle=Hematological%20oncology&rft.au=Morschhauser,%20F.&rft.date=2019-06&rft.volume=37&rft.issue=S2&rft.spage=135&rft.epage=137&rft.pages=135-137&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.95_2629&rft_dat=%3Cproquest_cross%3E2242708483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242708483&rft_id=info:pmid/&rfr_iscdi=true |